# Caihong Zeng

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/caihong-zeng/

## Facts

| Field | Value |
| --- | --- |
| Citations | 9,405 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 50 |
| i10-index | 136 |
| Last Known Institution | Nanjing University |
| OpenAlex ID | https://openalex.org/A5012536776 |
| ORCID iD | 0000-0002-3816-5164 |
| Works | 244 |

## Researcher papers

- [Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group](https://scholariq.org/papers/oxford-classification-of-iga-nephropathy-2016-an-update-from-the-iga-nephropathy/)
- [Anti-Phospholipase A2 Receptor Antibody in Membranous Nephropathy](https://scholariq.org/papers/anti-phospholipase-a2-receptor-antibody-in-membranous-nephropathy/)
- [Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population](https://scholariq.org/papers/long-term-renal-survival-and-related-risk-factors-in-patients-with-iga/)
- [Multitarget Therapy for Induction Treatment of Lupus Nephritis](https://scholariq.org/papers/multitarget-therapy-for-induction-treatment-of-lupus-nephritis/)
- [Renal histologic changes and the outcome in patients with diabetic nephropathy](https://scholariq.org/papers/renal-histologic-changes-and-the-outcome-in-patients-with-diabetic-nephropathy/)
- [Prediction and Risk Stratification of Kidney Outcomes in IgA Nephropathy](https://scholariq.org/papers/prediction-and-risk-stratification-of-kidney-outcomes-in-iga-nephropathy/)
- [Podocyte Lesions in Patients With Obesity-Related Glomerulopathy](https://scholariq.org/papers/podocyte-lesions-in-patients-with-obesity-related-glomerulopathy/)
- [Changes in the Spectrum of Kidney Diseases: An Analysis of 40,759 Biopsy-Proven Cases from 2003 to 2014 in China](https://scholariq.org/papers/changes-in-the-spectrum-of-kidney-diseases-an-analysis-of-40-759-biopsy-proven/)
- [Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial](https://scholariq.org/papers/mycophenolate-mofetil-combined-with-prednisone-versus-full-dose-prednisone-in/)
- [Diagnosis, Pathogenesis, Treatment, and Prognosis of Hereditary Fibrinogen Aα-Chain Amyloidosis](https://scholariq.org/papers/diagnosis-pathogenesis-treatment-and-prognosis-of-hereditary-fibrinogen-a-chain/)
- [Risk Factors for Renal Survival in Chinese Patients with Myeloperoxidase-ANCA–Associated GN](https://scholariq.org/papers/risk-factors-for-renal-survival-in-chinese-patients-with-myeloperoxidase-anca/)
- [Improvement of Outcomes in Patients with Lupus Nephritis: Management Evolution in Chinese Patients from 1994 to 2010](https://scholariq.org/papers/improvement-of-outcomes-in-patients-with-lupus-nephritis-management-evolution-in/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [Nanjing University](https://scholariq.org/institutions/nanjing-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.